Detalhe da pesquisa
1.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420467
2.
Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2.
Cancer
; 124(9): 1982-1991, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451696
3.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935773
4.
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer.
Cancer Invest
; 35(6): 386-392, 2017 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426267
5.
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Breast Cancer Res Treat
; 152(3): 557-67, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26155975
6.
Sorafenib and everolimus in advanced clear cell renal carcinoma: a phase I/II trial of the SCRI Oncology Research Consortium.
Cancer Invest
; 31(5): 323-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23614653
7.
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer.
Breast Cancer Res Treat
; 123(2): 471-5, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20658263
8.
Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer.
Cancer Invest
; 28(4): 408-12, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20210519
9.
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 8(7): 480-5, 498, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20864916
10.
A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer.
Clin Breast Cancer
; 19(1): 1-9, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30245148
11.
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
Front Oncol
; 9: 624, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355141
12.
A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.
Clin Breast Cancer
; 8(5): 425-31, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18952556
13.
A randomized phase II trial of oral topotecan versus docetaxel in the second-line treatment of non-small-cell lung cancer.
Clin Lung Cancer
; 9(3): 154-9, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18621625
14.
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
Lung Cancer
; 117: 38-43, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496254
15.
Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.
Clin Lung Cancer
; 8(8): 483-7, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17922972
16.
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
Lung Cancer
; 113: 79-84, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29110854
17.
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Oncology (Williston Park)
; 17(5 Suppl 5): 41-5, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12800606
18.
High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Clin Genitourin Cancer
; 11(3): 283-289.e1, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23684421
19.
Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.
Clin Colorectal Cancer
; 11(1): 45-52, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21840771
20.
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.
Lung Cancer
; 77(2): 359-64, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22560921